Coronary thrombolysis with intravenous anisoylated plasminogen-streptokinase complex BRL 26921.

BRL 26921 is a protected plasminogen-streptokinase complex with selective affinity for thrombus. When given intravenously within three hours of the onset of a first acute myocardial infarction angiographic patency of the infarct related vessel was seen in all 16 patients receiving the active drug co...

Fuld beskrivelse

Bibliografiske detaljer

Udgivet i:	Br Heart J
Principais autores:	Been, M, de Bono, D P, Muir, A L, Boulton, F E, Hillis, W S, Hornung, R
Format:	Artigo
Sprog:	Inglês
Udgivet:	BMJ Publishing Group 1985
Fag:	Research Article
Online adgang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC481752/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3882107/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/hrt.53.3.253
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!